Durolane SJ – stabilized hyaluronic acid, intended for single injection.
Product is CE marked in the European Union and intended for the symptomatic relief and palliative treatment of mild to moderate degenerative joint diseases such as osteoarthritis, conjointly labeled with a specific disposable tissue ablation device (coblation) capable of debriding without damaging soft tissues.
The package includes:
- 1 x 1 ml syringe
Ingredients of the product:
- stabilized hyaluronic acid
- saline sodium chloride solution, pH 7
The advantages of utilizing of Durolane SJ:
- Symptomatic relief in mild to moderate osteoarthritis of the knee and hip joints
Product Application Guidelines:
DUROLANE SJ is a single-injection, single-treatment solution and should only be given once in the treatment cycle. For the small synovial joints (wrist/hands), 1 mL, medium size joint (elbow/ankle) is about 1–2 mL
If a 2 ml dosage is required for injection into the joint, an additional syringe containing DUROLANE SJ will be necessary. For large joints, DUROLANE is available in a 3 ml syringe format.
DUROLANE SJ should be administered only by a licensed physician (or other professionals as required per local regulations) who is skilled in the use of synovial joint injection and requires medical facilities for performing intra-articular injections.
DUROLANE SJ must be administered using strict aseptic technique.
DUROLANE SJ should be exclusively injected into the joint cavity.
